Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.Institution: In the first half of 2024, the scale of China's edge cloud market increased by 21% year-on-year. Recently, the latest report "China Edge Cloud Market Tracking Research, 2024H1" released by International Data Corporation (IDC) shows that in the first half of 2024, the scale of China's edge cloud market totaled 5.48 billion yuan, with a year-on-year growth rate of 21.0%. Among them, the market scale of edge public cloud services, edge exclusive cloud services and edge cloud solutions reached RMB 3.00 billion, RMB 970 million and RMB 1.50 billion respectively. Internet audio and video distribution and real-time interaction based on edge resources, edge game clothes, cloud terminals and cloud games, cloud network services, and lightweight IT architecture migration of local industry customers are the core driving forces for market growth in this period.Hanwei Technology and others set up a new company in Hubei, including geographic remote sensing information service business. The enterprise search APP shows that recently, Hubei Hanwei Water Technology Co., Ltd. was established, with Zhao Shuai as the legal representative and a registered capital of 10 million yuan. Its business scope includes: intelligent instrument manufacturing; Industrial automatic control system device manufacturing; Research and development of mechanical equipment; Intelligent control system integration; Internet of things equipment sales; Geographic remote sensing information service, etc. Enterprise survey shows that the company is jointly owned by Hanwei Water Technology (Henan) Co., Ltd. and Li Yuhua, a subsidiary of Hanwei Technology.
ExxonMobil: By 2030, we plan to invest about 140 billion US dollars in major projects and Permian basin development plans.China Overseas Development: The annual interest of "23 Zhonghai 04" will be paid on December 12th. On December 10th, China Overseas Development (00688.HK) announced that China Overseas Enterprise Development Group Co., Ltd., a wholly-owned subsidiary of the company, will pay the annual interest of "23 Zhonghai 04" on December 12th, totaling 96 million yuan. The total amount of bonds issued in this issue is 3 billion yuan, and the issuance period is 5 years. The coupon rate of bonds in this issue is 3.20%.According to a survey conducted by the Monetary Authority of Singapore, Singapore's GDP growth rate is expected to be 3.6% in 2024 (previously 2.6%) and 3.1% in the fourth quarter of 2024 (previously 2.2%).
Tang Daizhi, the former deputy chief economist of China Offshore Oil Group Co., Ltd., was investigated. According to the news from the Discipline Inspection and Supervision Team of China Offshore Oil Group Co., Ltd. and the Supervision Committee of Jiangsu Provincial Commission for Discipline Inspection, Tang Daizhi, the former deputy chief economist of China Offshore Oil Group Co., Ltd., the general manager of human resources department and the head of party organization department, is suspected of serious violation of discipline and law, and is currently under disciplinary review and supervision investigation by the Discipline Inspection and Supervision Team of China Offshore Oil Group Co., Ltd. and the Jiangsu Provincial Supervision Committee.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.Boeing also exposed nearly 1,000 layoffs. According to Xinhua News Agency, citing American media reports, American aircraft manufacturer Boeing will lay off employees again, involving nearly 1,000 people in Washington State and California. This batch of layoffs is part of Boeing's plan to lay off 17,000 people worldwide announced in October.
Strategy guide 12-13
Strategy guide
12-13